Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/SPERO-THERAPEUTICS-INC-38533873/news/Spero-Therapeutics-Announces-FDA-Acceptance-and-Priority-Review-of-New-Drug-Application-for-Tebipene-37453452/?utm_source=whatsapp&utm_medium=social&utm_campaign=share